Karcinom prostaty a radikální prostatektomie

31 Miloš Broďák a kol. 4 Odložená léčba 3. Suardi N, Capitanio U, Chun FK, Graefen M, Perrotte P, Schlomm T, Haese A, Huland H, Erbersdobler A, Montorsi F, Karakiewicz PI. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 2008; 113: 2068–2072. 4. Heidenreich A, Aus C, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 68–80. 5. Weissbach L, Schaefer C. Active surveillance for screen-detected prostate cancer – a strategy for the future? Aktuelle Urol. 2010; 41: 239–244. 6. Boccon-Gibod L, Davin JL, Coulange C, Culine S, Coloby P, Soulié M, Zerbib M, Richaud P. New perspectives in prostate cancer management. Prog Urol 2010; 20: 491–497. 7. Drouin SJ, Rouprêt M, Hamdy F, Mottet N. Active surveillance for localized prostate cancer. Prog Urol. 2010; 20 Suppl 3: 181–185. 8. Krakowsky Y, Loblaw A, Klotz L. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics. J Urol 2010; 184: 131–135. 9. Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J; National Prostate Cancer Register (NPCR) of Sweden. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst 2010; 102: 950–958. 10. Oliveira IS, Pontes-Junior J, Abe DK, Crippa A, Dall’oglio MF, Nesralah AJ, Leite KR, Reis ST, Srougi M. Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy. Int Braz J Urol. 2010; 36: 292–299. 11. Mufarrij P, Sankin A, Godoy G, Lepor H. Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy. Urology 2010; 76: 689–692. 12. Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ. Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols. Urology 2010; 75: 414–418. 13. Jeldres C, Suardi N, Walz J, Hutterer GC, Ahyai S, Lattouf JB, Haese A, Graefen M, Erbersdobler A, Heinzer H, Huland H, Karakiewicz PI. Validation of the con- temporary epstein criteria for insignificant prostate cancer in European men. Eur Urol 2008; 54: 1306–1313.